Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Return on Sales (2022 - 2025)

Historic Return on Sales for Atara Biotherapeutics (ATRA) over the last 4 years, with Q3 2025 value amounting to 1.25%.

  • Atara Biotherapeutics' Return on Sales fell 7000.0% to 1.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year increase of 14800.0%. This contributed to the annual value of 0.66% for FY2024, which is 315800.0% up from last year.
  • Latest data reveals that Atara Biotherapeutics reported Return on Sales of 1.25% as of Q3 2025, which was down 7000.0% from 0.14% recorded in Q2 2025.
  • Over the past 5 years, Atara Biotherapeutics' Return on Sales peaked at 0.39% during Q1 2025, and registered a low of 337.9% during Q4 2022.
  • In the last 4 years, Atara Biotherapeutics' Return on Sales had a median value of 1.25% in 2025 and averaged 36.94%.
  • Within the past 5 years, the most significant YoY rise in Atara Biotherapeutics' Return on Sales was 3236300bps (2023), while the steepest drop was -746600bps (2023).
  • Atara Biotherapeutics' Return on Sales (Quarter) stood at 337.9% in 2022, then skyrocketed by 96bps to 14.28% in 2023, then surged by 97bps to 0.39% in 2024, then crashed by -222bps to 1.25% in 2025.
  • Its last three reported values are 1.25% in Q3 2025, 0.14% for Q2 2025, and 0.39% during Q1 2025.